Diabetes reduces vascular tetrahydrobiopterin levels by oxidation: Insights from a GTPCH-transgenic mouse model

Diabetes reduces vascular tetrahydrobiopterin levels by oxidation: Insights from a GTPCH-transgenic mouse model

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Alp, N, Mussa, S, Goh, N, Cai, S, Channon, K
Formáid:	Conference item
Foilsithe / Cruthaithe:	2003

Míreanna comhchosúla

Increased endothelial tetrahydrobiopterin levels in GTPCH-transgenic mice
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2002)

Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2003)

Reduced levels of tetrahydrobiopterin in diabetic mouse model: Effects on endothelial function and nitric oxide (NO) synthase dimerisation
de réir: Cai, S, et al.
Foilsithe / Cruthaithe: (2004)

Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I over-expression
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2003)

Nitric oxide Bioavailability is preserved in diabetes by increased endothelial tetrahydrobiopterin synthesis in targeted GTP cyclohydrolase transgenic mice
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2003)

Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression.
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2003)

Regulation of endothelial nitric oxide synthase (eNOS) by tetrahydrobiopterin in vascular disease
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2004)

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2004)

Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation.
de réir: Cai, S, et al.
Foilsithe / Cruthaithe: (2005)

Endothelial tetrahydrobiopterin regulates eNOS coupling/uncoupling independent of vascular disease: Insights from targeted transgenic models
de réir: Bendall, J, et al.
Foilsithe / Cruthaithe: (2004)

huGTPCH Expressing S plus S-Antilles Mice Have Reduced Gardos Channel Activity, Endothelin-1 Expression, and Endothelin Receptor A and B Expression, While Total Biopterin and Percent Tetrahydrobiopterin Are Increased
de réir: Romero, JR, et al.
Foilsithe / Cruthaithe: (2008)

The % tetrahydrobiopterin (BH4) and serine 1177 phosphorylation 19 reduced in sickle transgenic mice
de réir: Chen, Q, et al.
Foilsithe / Cruthaithe: (2007)

GTPCH I overexpression decreases atherosclerotic lesion formation in apolipoprotein E-deficient/eNOS transgenic mice
de réir: Takaya, T, et al.
Foilsithe / Cruthaithe: (2004)

Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
de réir: Channon, K
Foilsithe / Cruthaithe: (2004)

Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
de réir: Schmidt, T, et al.
Foilsithe / Cruthaithe: (2010)

Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse.
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2004)

Tetrahydrobiopterin (BH4) Improves Endothelial Cell Survival After Vascular Injury
de réir: Rinze, R, et al.
Foilsithe / Cruthaithe: (2008)

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2004)

Increased endothelial tetrahydrobiopterin reduces in stent stenosis in apolipoprotein E-knockout mice
de réir: Ali, Z, et al.
Foilsithe / Cruthaithe: (2007)

Nitric oxide bioactivity in ApoE -/- mice is maintained by increased endothelial tetrahydrobiopterin synthesis via targeted GTP cyclohydrolase-1 over-expression
de réir: Alp, N, et al.
Foilsithe / Cruthaithe: (2003)

Correction of tetrahydrobiopterin deficiency - Implications for dopa responsive dystonia and other inherited disorders of tetrahydrobiopterin metabolism
de réir: Heales, S, et al.
Foilsithe / Cruthaithe: (2005)

The relative contributions of cardiomyocytes versus endothelial cells to cardiac BH4 production; studies in novel cardiomyocyte- and endothelial-specific GTPCH I-deficient mice
de réir: Bendall, J, et al.
Foilsithe / Cruthaithe: (2012)

Increased Endothelial Tetrahydrobiopterin Reduces In Stent Stenosis in Apolipoprotein E-Knockout Mice
de réir: Ali, Z, et al.
Foilsithe / Cruthaithe: (2011)

Regulation of eNOS function by tetrahydrobiopterin in vascular disease
de réir: Channon, K
Foilsithe / Cruthaithe: (2004)

Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2005)

Tetrahydrobiopterin deficiency increases susceptibility to atherosclerosis
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2005)

Tetrahydrobiopterin and nitric oxide synthase recouplers
de réir: Channon, KM
Foilsithe / Cruthaithe: (2020)

Dihydrofolate reductase is required to maintain endothelial nitric oxide synthase coupling in vivo: Insights from methotrexate-treated BH4 deficient and GTPCH overexpressing mice
de réir: Crabtree, M, et al.
Foilsithe / Cruthaithe: (2010)

Endothelial tetrahydrobiopterin deficiency accelerates atherosclerotic progression by nitric oxide synthase uncoupling
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2005)

Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease.
de réir: Crabtree, M, et al.
Foilsithe / Cruthaithe: (2011)

Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease
de réir: Crabtree, M, et al.
Foilsithe / Cruthaithe: (2011)

Tetrahydrobiopterin: a vascular redox target to improve endothelial function.
de réir: Channon, K
Foilsithe / Cruthaithe: (2012)

Increased endothelial tetrahydrobiopterin synthesis reduces vein graft atherosclerosis in ApoE-knockout mice
de réir: Ali, Z, et al.
Foilsithe / Cruthaithe: (2005)

Low-dose Tetrahydrobiopterin Supplementation Reduces Atherosclerosis Progression in Apolipoprotein E-Knockout Mice via Effects on Vascular T cell Infiltration
de réir: Schmidt, T, et al.
Foilsithe / Cruthaithe: (2009)

Tetrahydrobiopterin deficiency uncouples nitric oxide synthase and causes pulmonary hypertension
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2004)

Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression.
de réir: Bendall, J, et al.
Foilsithe / Cruthaithe: (2005)

Tetrahydrobiopterin regulates vagal control of heart rate
de réir: Adlam, D, et al.
Foilsithe / Cruthaithe: (2005)

Tetrahydrobiopterin deficiency causes pulmonary hypertension: Effects on lung superoxide levels, hypoxic pulmonary vasoconstriction and vascular remodelling
de réir: Khoo, J, et al.
Foilsithe / Cruthaithe: (2004)

Tetrahydrobiopterin in the vascular system
de réir: Walter Roland, et al.
Foilsithe / Cruthaithe: (2001-08-01)

Tetrahydrobiopterin: coupling nitric oxide and redox signalling in cardiovascular disease
de réir: Channon, K
Foilsithe / Cruthaithe: (2012)